Bill Snyder
-
Schizophrenia ‘switches’ discovered
Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way. Read MoreSep 12, 2014
-
Meeting explores VUMC’s cultural renaissance
During presentations that were filled with messages about Vanderbilt University Medical Center’s purpose, addressing the “why” rather than detailing facts and figures, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, and C. Wright Pinson, MBA, M.D., deputy vice chancellor for Health Affairs and CEO of the Vanderbilt Health System, led the audience at Wednesday’s Fall Leadership Assembly through candid dialogue about VUMC’s way forward. Read MoreSep 11, 2014
-
Study tracks new way to fight HIV infection in women
Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection. Read MoreSep 11, 2014
-
Foundation grants bolster autism, dystonia research
Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder. Read MoreSep 4, 2014
-
Science educations bloom from ‘Simple Beginnings’
Vanderbilt University welcomed 99 new doctoral students last Friday, Aug. 29, during the fifth annual “Simple Beginnings” ceremony in a Light Hall lecture room packed with family members and other well-wishers. Read MoreSep 4, 2014
-
Diverse lineup set for Discovery Lecture series
Richard J. Smith, M.D., director of the Molecular Otolaryngology and Renal Research Laboratories (MORL) at the University of Iowa Carver College of Medicine, will begin the 2014-2015 Flexner Discovery Lecture Series on Thursday, Sept. 11. Read MoreAug 28, 2014
-
Ascano seeks to shed light on cellular stress response
Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses? Read MoreAug 28, 2014
-
Major grant spurs deeper look into ‘good cholesterol’
In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis. Read MoreAug 21, 2014
-
New technique accelerates genome editing process
It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease. Read MoreAug 21, 2014
-
Team takes 4-D look at brain receptor’s role
Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory. Read MoreAug 14, 2014
-
Conn lands Javits Neuroscience Investigator award
Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read MoreAug 7, 2014
-
Technique brings spinal cord neural signaling into focus
Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. Read MoreAug 5, 2014
-
Drug discovery clues in network map
Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read MoreAug 5, 2014
-
Doris Duke awards enhance clinical research training
Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Read MoreJul 31, 2014
-
Team spots trigger for rare diarrheal disease in infants
Researchers at Vanderbilt University, the University of Arizona and Phoenix Children’s Hospital have discovered what triggers a rare but devastating diarrheal disease in newborns that is fatal without intravenous feeding or intestinal transplant. Read MoreJul 24, 2014
-
Magnuson honored for role in Beta Cell Biology Consortium
Mark Magnuson, M.D., Louise B. McGavock Professor of Molecular Physiology and Biophysics at Vanderbilt University, has received a national leadership award for the Beta Cell Biology Consortium (BCBC), a major team science initiative. Read MoreJul 24, 2014
-
VU’s technology transfer efforts gain steam
Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year. Read MoreJul 24, 2014
-
Team effort boosts study of tachycardia syndrome
Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month. Read MoreJul 24, 2014
-
Colon cancer’s protein signatures identified
A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. Read MoreJul 24, 2014
-
Breast tissue growth protein may promote cancer: study
A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found. Read MoreJul 17, 2014